{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:38:12Z","timestamp":1761745092783},"reference-count":45,"publisher":"Japanese Circulation Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2019,12,10]]},"DOI":"10.1253\/circrep.cr-19-0100","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T17:07:23Z","timestamp":1573837643000},"page":"543-549","source":"Crossref","is-referenced-by-count":4,"title":["Neoatherosclerosis\u3000\u2015 Long-Term Assessment of Bioresorbable Vascular Scaffold \u2015"],"prefix":"10.1253","volume":"1","author":[{"given":"Noriaki","family":"Moriyama","sequence":"first","affiliation":[{"name":"Department of Cardiology and Catheterization Laboratories, Shonan Kamakura General Hospital"},{"name":"Department of Cardiology, Heart and Lung Center, Helsinki University and Helsinki University Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koki","family":"Shishido","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Catheterization Laboratories, Shonan Kamakura General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Catheterization Laboratories, Shonan Kamakura General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Laine","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heart and Lung Center, Helsinki University and Helsinki University Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Catheterization Laboratories, Shonan Kamakura General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease: Stent Restenosis Study Investigators. <i>N Engl J Med<\/i> 1994; 331: 496\u2013501.","DOI":"10.1056\/NEJM199408253310802"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sousa JE, Costa MA, Abizaid A, Abizaid AS, Feres F, Pinto IM, et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study. <i>Circulation<\/i> 2001; 103: 192\u2013195.","DOI":"10.1161\/01.CIR.103.2.192"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Weisz G, Leon MB, Holmes DR Jr, Kereiakes DJ, Popma JJ, Teirstein PS, et al. Five-year follow-up after sirolimus-eluting stent implantation: Results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial. <i>J Am Coll Cardiol<\/i> 2009; 53: 1488\u20131497.","DOI":"10.1016\/j.jacc.2009.01.050"},{"key":"4","unstructured":"4. Serruys PW, Garcia-Garcia HM, Onuma Y. From metallic cages to transient bioresorbable scaffolds: Change in paradigm of coronary revascularization in the upcoming decade? <i>Eur Heart J<\/i> 2012; 33: 16\u201325."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Otsuka F, Byrne RA, Yahagi K, Mori H, Ladich E, Fowler DR, et al. Neoatherosclerosis: Overview of histopathologic findings and implications for intravascular imaging assessment. <i>Eur Heart J<\/i> 2015; 36: 2147\u20132159.","DOI":"10.1093\/eurheartj\/ehv205"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yahagi K, Kolodgie FD, Otsuka F, Finn AV, Davis HR, Joner M, et al. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. <i>Nat Rev Cardiol<\/i> 2016; 13: 79\u201398.","DOI":"10.1038\/nrcardio.2015.164"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Moriyama N, Shishido K, Tanaka Y, Yokota S, Hayashi T, Miyashita H, et al. Neoatherosclerosis 5 years after bioresorbable vascular scaffold implantation. <i>J Am Coll Cardiol<\/i> 2018; 71: 1882\u20131893.","DOI":"10.1016\/j.jacc.2018.02.051"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Serruys PW, Onuma Y, Dudek D, Smits PC, Koolen J, Chevalier B, et al. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. <i>J Am Coll Cardiol<\/i> 2011; 58: 1578\u20131588.","DOI":"10.1016\/j.jacc.2011.05.050"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ellis SG, Kereiakes DJ, Metzger DC, Caputo RP, Rizik DG, Teirstein PS, et al. Everolimus-eluting bioresorbable scaffolds for coronary artery disease. <i>N Engl J Med<\/i> 2015; 373: 1905\u20131915.","DOI":"10.1056\/NEJMoa1509038"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kimura T, Kozuma K, Tanabe K, Nakamura S, Yamane M, Muramatsu T, et al. A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan. <i>Eur Heart J<\/i> 2015; 36: 3332\u20133342.","DOI":"10.1093\/eurheartj\/ehv435"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sabat\u00e9 M, Windecker S, I\u00f1iguez A, Okkels-Jensen L, Cequier A, Brugaletta S, et al. Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: Results of the randomized ABSORB ST-segment elevation myocardial infarction: Results of the randomized ABSORB ST-segment elevation myocardial infarction: TROFI II trial. <i>Eur Heart J<\/i> 2016; 37: 229\u2013240.","DOI":"10.1093\/eurheartj\/ehv500"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Gao R, Yang Y, Han Y, Huo Y, Chen J, Yu B, et al. Bioresorbable vascular scaffolds versus metallic stents in patients with coronary artery disease: ABSORB China Trial. <i>J Am Coll Cardiol<\/i> 2015; 66: 2298\u20132309.","DOI":"10.1016\/j.jacc.2015.09.054"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Puricel S, Arroyo D, Corpataux N, Baeriswyl G, Lehmann S, Kallinikou Z, et al. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds. <i>J Am Coll Cardiol<\/i> 2015; 65: 791\u2013801.","DOI":"10.1016\/j.jacc.2014.12.017"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Serruys PW, Chevalier B, Dudek D, Cequier A, Carri\u00e9 D, Iniguez A, et al. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): An interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial. <i>Lancet<\/i> 2015; 385: 43\u201354.","DOI":"10.1016\/S0140-6736(14)61455-0"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Cassese S, Byrne RA, Ndrepepa G, Kufner S, Wiebe J, Repp J, et al. Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: A meta-analysis of randomised controlled trials. <i>Lancet<\/i> 2016; 387: 537\u2013544.","DOI":"10.1016\/S0140-6736(15)00979-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Wykrzykowska JJ, Kraak RP, Hofma SH, van der Schaaf RJ, Arkenbout EK, IJsselmuiden AJ, et al. Bioresorbable scaffolds versus metallic stents in routine PCI. <i>N Engl J Med<\/i> 2017; 376: 2319\u20132328.","DOI":"10.1056\/NEJMoa1614954"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ali ZA, Serruys PW, Kimura T, Gao R, Ellis SG, Kereiakes DJ, et al. 2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: A systematic review and meta-analysis of seven randomised trials with an individual patient data substudy. <i>Lancet<\/i> 2017; 390: 760\u2013772.","DOI":"10.1016\/S0140-6736(17)31470-8"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Montone RA, Niccoli G, De Marco F, Minelli S, D\u2019Ascenzo F, Testa L, et al. Temporal trends in adverse events after everolimus-eluting bioresorbable vascular scaffold versus everolimus-eluting metallic stent implantation: A meta-analysis of randomized controlled trials. <i>Circulation<\/i> 2017; 135: 2145\u20132154.","DOI":"10.1161\/CIRCULATIONAHA.117.028479"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Kereiakes DJ, Ellis SG, Metzger DC, Caputo RP, Rizik DG, Teirstein PS, et al. Clinical outcomes prior to and following complete everolimus-eluting bioresorbable scaffold resorption: Five-year follow-up from the ABSORB III Trial. <i>Circulation<\/i>, doi:10.1161\/CIRCULATIONAHA.119.042584.","DOI":"10.1161\/CIRCULATIONAHA.119.042584"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ortega-Paz L, Capodanno D, Gori T, Nef H, Latib A, Caramanno G, et al. Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score. <i>EuroIntervention<\/i> 2017; 12: 2110\u20132117.","DOI":"10.4244\/EIJ-D-16-00974"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Stone GW, Abizaid A, Onuma Y, Seth A, Gao R, Ormiston J, et al. Effect of technique on outcomes following bioresorbable vascular scaffold implantation: Analysis from the ABSORB trials. <i>J Am Coll Cardiol<\/i> 2017; 70: 2863\u20132874.","DOI":"10.1016\/j.jacc.2017.09.1106"},{"key":"22","unstructured":"22. Yamaji K, R\u00e4ber L, Windecker S. What determines long-term outcomes using fully bioresorbable scaffolds: The device, the operator or the lesion? <i>EuroIntervention<\/i> 2017; 12: 1684\u20131687."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Onuma Y, Sotomi Y, Shiomi H, Ozaki Y, Namiki A, Yasuda S, et al. Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: Insights from the randomised ABSORB Japan trial. <i>EuroIntervention<\/i> 2016; 12: 1090\u20131101.","DOI":"10.4244\/EIJY16M09_01"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Romero ME, Yahagi K, Kolodgie FD, Virmani R. Neoatherosclerosis from a pathologist\u2019s point of view. <i>Arterioscler Thromb Vasc Biol<\/i> 2015; 35: e43\u2013e49.","DOI":"10.1161\/ATVBAHA.115.306251"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Taniwaki M, Radu MD, Zaugg S, Amabile N, Garcia-Garcia HM, Yamaji K, et al. Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography. <i>Circulation<\/i> 2016; 133: 650\u2013660.","DOI":"10.1161\/CIRCULATIONAHA.115.019071"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Mangiameli A, Ohno Y, Attizzani GF, Capodanno D, Tamburino C. Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold. <i>JACC Cardiovasc Interv<\/i> 2015; 8: 633\u2013634.","DOI":"10.1016\/j.jcin.2014.11.014"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Bastante T, Rivero F, Benedicto A, Cuesta J, Alfonso F. Recurrent neoatherosclerosis after bioresorbable vascular scaffold treatment of in-stent restenosis. <i>JACC Cardiovasc Interv<\/i> 2015; 8: 1264\u20131265.","DOI":"10.1016\/j.jcin.2015.03.031"},{"key":"28","unstructured":"28. Hiltrop N, Jorge C, Bennett J, Adriaenssens T. Late neoatherosclerotic scaffold failure: An unexpected Achilles heel for current bioresorbable scaffold technology? <i>Int J Cardiol<\/i> 2016; 223: 133\u2013135."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Sato T, Richardt G, Abdel-Wahab M. Early neoatherosclerosis after bioresorbable vascular scaffold implantation: Insights from optical coherence tomography. <i>Coron Artery Dis<\/i> 2016; 27: 616\u2013617.","DOI":"10.1097\/MCA.0000000000000391"},{"key":"30","unstructured":"30. Simsek C, Karanasos A, Magro M, Garcia-Garcia HM, Onuma Y, Regar E, et al. Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: Five-year results of multiple invasive imaging modalities. <i>EuroIntervention<\/i> 2016; 11: 996\u20131003."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Kang SH, Kang SJ, Kim WJ. Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold at 8 months. <i>JACC Cardiovasc Interv<\/i> 2017; 10: 1896\u20131898.","DOI":"10.1016\/j.jcin.2017.07.018"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Yamaji K, Ueki Y, Souteyrand G, Daemen J, Wiebe J, Nef H, et al. Mechanisms of very late bioresorbable scaffold thrombosis: The INVEST Registry. <i>J Am Coll Cardiol<\/i> 2017; 70: 2330\u20132344.","DOI":"10.1016\/j.jacc.2017.09.014"},{"key":"33","unstructured":"33. Otsuka F, Sakakura K, Yahagi K, Joner M, Virmani R. Has our understanding of calcification in human coronary atherosclerosis progressed? <i>Arterioscler Thromb Vasc Biol<\/i> 2014; 34: 724\u2013736."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Jinnouchi H, Torii S, Sakamoto A, Kolodgie FD, Virmani R, Finn AV. Fully bioresorbable vascular scaffolds: Lessons learned and future directions. <i>Nat Rev Cardiol<\/i> 2019; 16: 286\u2013304.","DOI":"10.1038\/s41569-018-0124-7"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Zeng Y, Tateishi H, Cavalcante R, Tenekecioglu E, Suwannasom P, Sotomi Y, et al. Serial assessment of tissue precursors and progression of coronary calcification analyzed by fusion of IVUS and OCT: 5-year follow-up of scaffolded and nonscaffolded arteries. <i>JACC Cardiovasc Imaging<\/i> 2017; 10: 1151\u20131161.","DOI":"10.1016\/j.jcmg.2016.11.016"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Lee SY, Hur SH, Lee SG, Kim SW, Shin DH, Kim JS, et al. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation. <i>Circ Cardiovasc Interv<\/i> 2015; 8: e001878.","DOI":"10.1161\/CIRCINTERVENTIONS.114.001878"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Lee SY, Ahn JM, Mintz GS, Hur SH, Choi SY, Kim SW, et al. Characteristics of earlier versus delayed presentation of very late drug-eluting stent thrombosis: An optical coherence tomographic study. <i>J AM Heart Assoc<\/i> 2017; 6: pii: e005386.","DOI":"10.1161\/JAHA.116.005386"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Moriyama N, Shishido K, Tobita K, Takada T, Ochiai T, Tsukuda S, et al. Persistent bioresorbable vascular scaffold by optical coherence tomography imaging at 5 years. <i>JACC Cardiovasc Interv<\/i> 2017; 10: e11\u2013e13.","DOI":"10.1016\/j.jcin.2016.11.008"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. <i>Lancet<\/i> 2009; 373: 897\u2013910.","DOI":"10.1016\/S0140-6736(09)60325-1"},{"key":"40","doi-asserted-by":"crossref","unstructured":"41. Gomez-Lara J, Brugaletta S, Ortega-Paz L, Vandeloo B, Moscarella E, Salas M, et al. Long-term coronary functional assessment of the infarct-related artery treated with everolimus-eluting bioresorbable scaffolds or everolimus-eluting metallic stents: Insights of the TROFI II Trial. <i>JACC Cardiovasc Interv<\/i> 2018; 11: 1559\u20131571.","DOI":"10.1016\/j.jcin.2018.04.026"},{"key":"41","doi-asserted-by":"crossref","unstructured":"42. Ishii M, Kaikita K, Sato K, Tanaka T, Sugamura K, Sakamoto K, et al. Acetylcholine-provoked coronary spasm at site of significant organic stenosis predicts poor prognosis in patients with coronary vasospastic angina. <i>J Am Coll Cardiol<\/i> 2015; 66: 1105\u20131115.","DOI":"10.1016\/j.jacc.2015.06.1324"},{"key":"42","doi-asserted-by":"crossref","unstructured":"43. Karanasos A, Simsek C, Gnanadesigan M, van Ditzhuijzen NS, Freire R, Dijkstra J, et al. OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold. <i>J Am Coll Cardiol<\/i> 2014; 64: 2343\u20132356.","DOI":"10.1016\/j.jacc.2014.09.029"},{"key":"43","doi-asserted-by":"crossref","unstructured":"44. Serruys PW, Katagiri Y, Sotomi Y, Zeng Y, Chevalier B, van der Schaaf RJ, et al. Arterial remodeling after bioresorbable scaffolds and metallic stents. <i>J Am Coll Cardiol<\/i> 2017; 70: 60\u201374.","DOI":"10.1016\/j.jacc.2017.05.028"},{"key":"44","doi-asserted-by":"crossref","unstructured":"45. Onuma Y, Serruys PW, Muramatsu T, Nakatani S, van Geuns RJ, de Bruyn B, et al. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-eluting fully bioresorbable vascular scaffold: Optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). <i>JACC Cardiovasc Interv<\/i> 2014; 7: 1400\u20131411.","DOI":"10.1016\/j.jcin.2014.06.016"},{"key":"45","doi-asserted-by":"crossref","unstructured":"46. Iannaccone M, D\u2019Ascenzo F, Templin C, Omed\u00e8 P, Montefusco A, Guagliumi G, et al. Optical coherence tomography evaluation of intermediate-term healing of different stent types: Systemic review and meta-analysis. <i>Eur Heart J Cardiovasc Imaging<\/i> 2017; 18: 159\u2013166.","DOI":"10.1093\/ehjci\/jew070"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/1\/12\/1_CR-19-0100\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T22:20:11Z","timestamp":1576275611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/1\/12\/1_CR-19-0100\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,10]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-19-0100","relation":{},"ISSN":["2434-0790"],"issn-type":[{"value":"2434-0790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,10]]}}}